– Biotech CEO advancing Alzheimer’s disease treatment sees thaw in “nuclear winter” of funding
– Life science firms shine at tech awards
– Golden Seeds looks to invest in female entrepreneurs
– Pittsburgh proves essential to the story of Cognition Therapeutics
– Cognition Therapeutics seeks help with Alzheimers clinical trial
– Cognition Therapeutics Completes $2.5M in Series A1 Financing
– Cognition Therapeutics raises 2.5 Millions
– Innovation Works, Cognition Therapeutics highlighted in Pittsburgh Post-Gazette
– Tech, life sciences VC funding takes hit in 2009
– Cognition Therapeutics featured in The Economist’s G20 conference coverage
– BioWorld Today profiles Cognition Therapeutics
– Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzeimer's Disease
– PghTech Women’s Network raises Alzheimer’s awareness by highlighting cutting-edge research
– Cognition Therapeutics Profiled in Pittsburgh Post-Gazette
– Cognition’s Chief Science Officer chairs scientific session at SRI 11th Annual Alzheimer’s disease meeting in Boston, MA – summary of CogRx presentation
– Cognition Therapeutics celebrates Innovation Work’s 100th Investment
– Cognition Therapeutics receives funding from Pittsburgh Life Sciences Greenhouse
